Sign in

CIK 0001563880

  • Non-accelerated filer
  • Smaller reporting company

Trevi Therapeutics, Inc.

Sign in to watch
Ticker
TRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450834299
Phone
+1 203-304-2499
Business address
195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$595,806
in 1 filing, $596K under 10b5-1 plans

Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Heffernan Michael Thomas −$596K Director sold 86% of stake

Reading 6 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-10-18 New Enterprise Associates 16, L.P. 10% owner Purchase +1,851,852 7,789,850
2021-10-18 New Enterprise Associates 16, L.P. 10% owner Purchase · 3.5-Year Common Stock Warrant +1,851,852 1,851,852
2021-10-18 New Enterprise Associates 16, L.P. 10% owner Purchase · 7-Year Common Stock Warrant +1,851,852 1,851,852
2021-08-09 Delfini Lisa Chief Financial Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2021-06-16 Mathers Edward T Director Grant or award · Nonstatutory Stock Option (right to buy) +20,000 20,000
2021-06-16 VANLENT ANNE Director Grant or award · Nonstatutory Stock Option (right to buy) +20,000 20,000
2021-06-16 Cassella James V Director Grant or award · Nonstatutory Stock Option (right to buy) +20,000 20,000
2021-06-16 Heffernan Michael Thomas Director Grant or award · Nonstatutory Stock Option (right to buy) +20,000 20,000
2021-06-16 Colangelo Dominick Director Grant or award · Nonstatutory Stock Option (right to buy) +20,000 20,000
2021-06-16 Meeker David P Director Grant or award · Nonstatutory Stock Option (right to buy) +20,000 20,000
2021-04-13 Galletta Christopher Grant or award · Stock Option (right to buy) +25,000 25,000
2021-02-17 GOOD JENNIFER L President & CEO Grant or award · Stock Option (right to buy) +160,000 160,000
2021-02-17 Muscolo Frank P Controller Grant or award · Stock Option (right to buy) +30,000 30,000
2021-02-17 Seiter Christopher Chief Financial Officer Grant or award · Stock Option (right to buy) +80,000 80,000
2021-02-17 SCIASCIA THOMAS Chief Medical Officer Grant or award · Stock Option (right to buy) +50,000 50,000
2021-02-01 Forbes William P Chief Development Officer Grant or award · Stock Option (right to buy) +200,000 200,000
2020-06-29 Colangelo Dominick Director Grant or award · Nonstatutory Stock Option (right to buy) +23,684 23,684
2020-06-11 Mathers Edward T Director Grant or award · Nonstatutory Stock Option (right to buy) +14,210 14,210
2020-06-11 VANLENT ANNE Director Grant or award · Nonstatutory Stock Option (right to buy) +14,210 14,210
2020-06-11 Heffernan Michael Thomas Director Grant or award · Nonstatutory Stock Option (right to buy) +14,210 14,210

Page 13 of 21 · 419 trades